Large-scale testing (Phase 3)Ended earlyNCT06125028What this trial is testing[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone LymphomaWho this might be right forMarginal Zone Lymphoma Pentixapharm AG 8
Testing effectiveness (Phase 2)Study completedNCT04338867What this trial is testingNitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC PatientsWho this might be right forPhase II Clinical TrialNinety-six Histologically Confirmed NSCLC Patients With BMRandomized 1:1 to Received TN Plus WBR or Only WBR+1 more Instituto Nacional de Cancerologia de Mexico 96
Early research (Phase 1)Study completedNCT01324479What this trial is testingStudy of INC280 in Patients With c-MET Dependent Advanced Solid TumorsWho this might be right forSolid Tumors Novartis Pharmaceuticals 131
Early research (Phase 1)Ended earlyNCT01548924What this trial is testingDetermination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid TumorsWho this might be right forSolid Tumors Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Testing effectiveness (Phase 2)WithdrawnNCT04665115What this trial is testingIbrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)Who this might be right forAsymptomatic COVID-19 Infection Laboratory-ConfirmedB-Cell NeoplasmChronic Lymphocytic Leukemia+6 more Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Looking for participantsNCT06097468What this trial is testingNisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)Who this might be right forOral Cavity Squamous Cell Carcinoma University of California, San Francisco 40
Early research (Phase 1)Active Not RecruitingNCT07584668What this trial is testingSafety, Tolerability and Pharmacokinetics of EM-I-2024Who this might be right forAssess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor National Medical Research Radiological Centre of the Ministry of Health of Russia 24
Testing effectiveness (Phase 2)Study completedNCT04180215What this trial is testingA Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other CancersWho this might be right forHPV-Related Squamous Cell Carcinoma Hookipa Biotech GmbH 198
Testing effectiveness (Phase 2)Study completedNCT00386815What this trial is testingSafety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Eli Lilly and Company 20
Not applicableActive Not RecruitingNCT00860652What this trial is testingRadiotherapy - Adjuvant Versus Early SalvageWho this might be right forProstate Cancer Trans Tasman Radiation Oncology Group 333
Early research (Phase 1)Study completedNCT01795586What this trial is testingA Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast PatientsWho this might be right forBreast Cancer H. Lee Moffitt Cancer Center and Research Institute 19
Testing effectiveness (Phase 2)Looking for participantsNCT05841550What this trial is testingThe TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple MyelomaWho this might be right forMultiple MyelomaSmoldering Multiple Myeloma Oslo University Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT02174445What this trial is testingAn Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two YearsWho this might be right forChronic Myeloid Leukemia Prof. Dr. Nikolas von Bubnoff 14
Not applicableLooking for participantsNCT07173868What this trial is testingFDG PET-CT in Advanced Breast CancerWho this might be right forHistologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT Samsung Medical Center 100
Early research (Phase 1)Study completedNCT01165905What this trial is testingSafety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid TumorsWho this might be right forSolid Tumor Traws Pharma, Inc. 10
Early research (Phase 1)Study completedNCT02036281What this trial is testingSubstance P-Saporin in Terminal Cancer Patients With Intractable PainWho this might be right forTerminally IllHistologically-confirmed Advanced CancerPain, Intractable University of Texas Southwestern Medical Center 23
Early research (Phase 1)Study completedNCT00509301What this trial is testingSafety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma MultiformeWho this might be right forRecurrent Glioblastoma Multiforme Peregrine Pharmaceuticals 12
Testing effectiveness (Phase 2)Looking for participantsNCT07391813What this trial is testingSNB-101 for Treatment of Extensive Stage Small Cell Lung CancerWho this might be right forPatient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC) SN BioScience 55
Early research (Phase 1)Study completedNCT01320592What this trial is testingPD0332991/Paclitaxel in Advanced Breast CancerWho this might be right forBreast Cancer Abramson Cancer Center at Penn Medicine 28
Post-approval studies (Phase 4)Study completedNCT00220311What this trial is testingConfirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Genzyme, a Sanofi Company 10